Abstract Details

Title Neuropathy as an adverse effect of vascular endothelial growth factor tyrosine kinase inhibitors, a meta-analysis of randomized clinical trials

Topic Neuro-oncology

Presentation(s) P6 - (-)

Poster/Presentation
Number 098

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Bhaskar Roy, MD, FAAN (Yale University) PRESENTER	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file